RNAi/MicroRNA Market Analysis & Business Tutorial
February 19, 2008 (13:30—17:30)
Stockholm, Sweden
At this fast-paced business-focused tutorial, as well as learning about the latest market status and opportunities, you will have the opportunity to ask specific questions to assist your own business development plans.
Presented by Enal Razvi, Ph.D., a very experienced analyst in the biotech sector, this tutorial will be held during the Screening Europe Conference. Attendees will also have the opportunity of acquiring the new RNAi Therapeutics 2008 Market Report or the new MicroRNA 2008 Market Report in the delegate package. The package represents a considerable saving over normal list price. Please click the Registration tab on the left-hand side for pricing options.
Introduction to the Tutorial
This market analysis and business tutorial is designed to provide a complete overview and analysis of the RNAi Research Tools, RNAi Therapeutics, and microRNA markets. These three market segments are among the most active spaces in life science research and drug discovery and Select Biosciences feels that they are most appropriately presented adjacent to our Screening Conference with a large number of pharmaceutical and biotechnology delegates. The tutorial will present the market landscape in qualitative and quantitative terms and more specifically present analysis from market surveys that Select Biosciences has recently performed as part of its continuing industry coverage.
Topics Covered in this Tutorial
- Technology Overview of the RNAi and microRNA Spaces
- RNAi in the Research Tools Space—Qualitative and Quantitative Market Trends based on End-User Market Surveys
- SWOT Analysis of the Marketplace
- Niches of Market Opportunity
- MicroRNA Market Trends—Current Market Landscape, Quantitative Market Analysis, Niches of Market Opportunity
- MicroRNA market survey data provides current picture of this emerging space and highlights the products from the various vendors that are penetrating the space
- Provides up-to-date end-user utilization data: Reporting on the marketplace
- RNAi Therapeutics Landscape
- Technology Trends
- Current pipeline of RNAi-based Therapeutics
- Companies in the RNAi Therapeutics Space and Their Current Pipeline and associated SWOT Analysis
Who Should Attend
• Scientists in Pharmaceutical and Biotechnology companies
• Business Development Executives in Pharmaceutical and Biotechnology companies
• Representatives from Academic Institutions
• Established and start-up companies in RNAi and microRNA spaces and vendors currently offering or seeking to offer products into these spaces
• Venture Capital community and investors seeking to understand the these markets, and associated business opportunities and intellectual property landscape
Learning Objectives/Themes
• Overview of the market landscape in the RNAi and microRNA markets—these are fast-moving and evolving spaces and Select Biosciences’ analysis is up-to-date and complete
• Market analysis and quantitative trends
• Emerging business opportunities and associated challenges
• Review of the various technologies in these spaces
• Interactive round table moderated discussion